These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8380983

  • 1. Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.
    Vouret-Craviari V, Van Obberghen-Schilling E, Scimeca JC, Van Obberghen E, Pouysségur J.
    Biochem J; 1993 Jan 01; 289 ( Pt 1)(Pt 1):209-14. PubMed ID: 8380983
    [Abstract] [Full Text] [Related]

  • 2. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity.
    Meloche S, Seuwen K, Pagès G, Pouysségur J.
    Mol Endocrinol; 1992 May 01; 6(5):845-54. PubMed ID: 1603090
    [Abstract] [Full Text] [Related]

  • 3. Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk.
    Meloche S, Pagès G, Pouysségur J.
    Mol Biol Cell; 1992 Jan 01; 3(1):63-71. PubMed ID: 1372523
    [Abstract] [Full Text] [Related]

  • 4. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition.
    Kahan C, Seuwen K, Meloche S, Pouysségur J.
    J Biol Chem; 1992 Jul 05; 267(19):13369-75. PubMed ID: 1320018
    [Abstract] [Full Text] [Related]

  • 5. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts.
    Lenormand P, Sardet C, Pagès G, L'Allemain G, Brunet A, Pouysségur J.
    J Cell Biol; 1993 Sep 05; 122(5):1079-88. PubMed ID: 8394845
    [Abstract] [Full Text] [Related]

  • 6. Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.
    Van Obberghen-Schilling E, Rasmussen UB, Vouret-Craviari V, Lentes KU, Pavirani A, Pouysségur J.
    Biochem J; 1993 Jun 15; 292 ( Pt 3)(Pt 3):667-71. PubMed ID: 7686363
    [Abstract] [Full Text] [Related]

  • 7. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis.
    Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq JP, Pouysségur J.
    Mol Biol Cell; 1992 Jan 15; 3(1):95-102. PubMed ID: 1312881
    [Abstract] [Full Text] [Related]

  • 8. The mitogenic signaling pathway of fibroblast growth factor is not mediated through polyphosphoinositide hydrolysis and protein kinase C activation in hamster fibroblasts.
    Magnaldo I, L'Allemain G, Chambard JC, Moenner M, Barritault D, Pouysségur J.
    J Biol Chem; 1986 Dec 25; 261(36):16916-22. PubMed ID: 3023371
    [Abstract] [Full Text] [Related]

  • 9. Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation.
    Burt AR, Carr IC, Mullaney I, Anderson NG, Milligan G.
    Biochem J; 1996 Nov 15; 320 ( Pt 1)(Pt 1):227-35. PubMed ID: 8947492
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase-activating growth factors potentiate thrombin- and AIF4- -induced phosphoinositide breakdown in hamster fibroblasts. Evidence for positive cross-talk between the two mitogenic signaling pathways.
    Paris S, Chambard JC, Pouysségur J.
    J Biol Chem; 1988 Sep 15; 263(26):12893-900. PubMed ID: 2843502
    [Abstract] [Full Text] [Related]

  • 11. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells.
    Balmanno K, Cook SJ.
    Oncogene; 1999 May 20; 18(20):3085-97. PubMed ID: 10340380
    [Abstract] [Full Text] [Related]

  • 12. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.
    Pagès G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouysségur J.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8319-23. PubMed ID: 8397401
    [Abstract] [Full Text] [Related]

  • 13. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells.
    Reilly CF, Connolly TM, Feng DM, Nutt RF, Mayer EJ.
    Biochem Biophys Res Commun; 1993 Feb 15; 190(3):1001-8. PubMed ID: 8382482
    [Abstract] [Full Text] [Related]

  • 14. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases.
    McKenzie FR, Pouysségur J.
    J Biol Chem; 1996 Jun 07; 271(23):13476-83. PubMed ID: 8662790
    [Abstract] [Full Text] [Related]

  • 15. Mitogenic effects of fibroblast growth factors in cultured fibroblasts. Interaction with the G-protein-mediated signaling pathways.
    Paris S, Pouysségur J.
    Ann N Y Acad Sci; 1991 Jun 07; 638():139-48. PubMed ID: 1664681
    [Abstract] [Full Text] [Related]

  • 16. Insulin induction of protein kinase C alpha expression is independent of insulin receptor Tyr1162/1163 residues and involves mitogen-activated protein kinase kinase 1 and sustained activation of nuclear p44MAPK.
    Antoine PJ, Bertrand F, Auclair M, Magré J, Capeau J, Cherqui G.
    Endocrinology; 1998 Jul 07; 139(7):3133-42. PubMed ID: 9645686
    [Abstract] [Full Text] [Related]

  • 17. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.
    Chen Y, Grall D, Salcini AE, Pelicci PG, Pouysségur J, Van Obberghen-Schilling E.
    EMBO J; 1996 Mar 01; 15(5):1037-44. PubMed ID: 8605873
    [Abstract] [Full Text] [Related]

  • 18. Fluoride at mitogenic doses induces a sustained activation of p44mapk, but not p42mapk, in human TE85 osteosarcoma cells.
    Wu LW, Yoon HK, Baylink DJ, Graves LM, Lau KH.
    J Clin Endocrinol Metab; 1997 Apr 01; 82(4):1126-35. PubMed ID: 9100584
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets.
    Börsch-Haubold AG, Kramer RM, Watson SP.
    Biochem J; 1996 Aug 15; 318 ( Pt 1)(Pt 1):207-12. PubMed ID: 8761473
    [Abstract] [Full Text] [Related]

  • 20. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts.
    Chen YH, Pouysségur J, Courtneidge SA, Van Obberghen-Schilling E.
    J Biol Chem; 1994 Nov 04; 269(44):27372-7. PubMed ID: 7525555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.